Clinical Trial Update: Safety of the EnvPro HIV Vaccine in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial reports the safety of the EnvPro HIV Vaccine in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EnvPro HIV Vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED